Cinanserin (INN) is a 5-HT2A and 5-HT2C receptor antagonist which was discovered in the 1960s.[1]
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
ChemSpider |
|
UNII |
|
ChEBI |
|
ChEMBL |
|
CompTox Dashboard (EPA) |
|
ECHA InfoCard | 100.220.552 |
Chemical and physical data | |
Formula | C20H24N2OS |
Molar mass | 340.49 g·mol−1 |
3D model (JSmol) |
|
| |
| |
(what is this?) (verify) |
The molecule is an inhibitor of the 3C-like protease of SARS-coronavirus (SARS).[2]